Diabetes/Prediabetes/Hypoglycemia
Poster Presentations
Olayemi Adeniran, MD (he/him/his)
Resident
Brookdale University Hospital and Medical Center
Brooklyn, New York, United States
Olayemi Adeniran, MD (he/him/his)
Resident
Brookdale University Hospital and Medical Center
Brooklyn, New York, United States
Samrah Siddiqui, MD (she/her/hers)
PGY-2
Brookdale University Hospital, One Brooklyn Health. NY
Omolara G. Adeniran, MD (she/her/hers)
Endocrinology Fellow
SUNY Downstate Medical Center University Hospital
Brooklyn, New York, United States
Anemia is prevalent among patients with diabetes mellitus. However, data regarding the impact of anemia on diabetic complications are scanty. Therefore, we aimed to investigate the outcomes of diabetes mellitus in patients with anemia.
Methods:
We analyzed National Inpatient Sample (NIS) between 2016 -2020. We included all patients aged 18 years and older with primary and secondary diagnoses of diabetes mellitus using International Classification Codes, 10th Revision (ICD-10) codes. The overall study population was further stratified by anemia status. We conducted a multivariable logistic regression to investigate the outcomes of diabetes mellitus among those with anemia, including microvascular complications (nephropathy, retinopathy, and peripheral circulatory) and macrovascular complications (coronary artery disease, peripheral arterial disease, and stroke).
Results:
A total of 7,546,565 individuals with diabetes mellitus were identified within the study period, of which 26% (1,960,298) had comorbid anemia and 74% (5586,267) had no anemia. After controlling for age, sex, race, and comorbidities, including hypertension, heart failure, renal failure, obesity, and liver failure, we found increased microvascular complications among individuals with comorbid anemia, including nephropathy (OR 1.49, CI: 1.48-1.51), retinopathy(OR 0.54, CI:1.52-1.56 ), neuropathy (OR 1.29, CI: 1.28 – 1.29), peripheral circulatory (OR 1.45, CI:1.44 – 1.46) and macrovascular complication, peripheral arterial disease (OR 1.41, CI:1.40 – 1.41).
Discussion/Conclusion:
Our results highlight the extent to which anemia impacts diabetic complications. Additionally, they emphasize the clinical awareness needed to manage anemia in patients with diabetes.